On Tuesday, Repligen Corporation (NASDAQ:RGEN) purchased 908 Devices Inc.’s (NASDAQ:MASS) desktop portfolio of four devices for bioprocessing process analytical technology (PAT) applications. The ...
(RTTNews) - Repligen Corporation (RGEN) announced the acquisition of a desktop bioprocessing analytical technology portfolio from 908 Devices for $70 million in cash. The portfolio includes four ...
Repligen purchased 908 Devices’s desktop portfolio of four devices for bioprocessing process analytical technology (PAT) applications. 908 Devices remains focused on the growth of its newly expanded ...
Repligen Corp. acquired 908 Devices Inc.’s desktop portfolio of four devices for bioprocessing process analytical technology (PAT) applications for $70 million in cash.
Repligen Corporation (NASDAQ:RGEN), a $9.36 billion market cap leader in bioprocessing technology, has been navigating a complex market landscape characterized by innovation, strategic acquisitions, ...
Portfolio includes PAT devices for real-time process monitoring, control and analysis The addition of these desktop assets complements and strengthens Repligen’s differentiated PAT portfolio that ...
Portfolio includes PAT devices for real-time process monitoring, control and analysis Repligen Corporation (Nasdaq: RGEN), a life sciences company focused on bioprocessing technology leadership, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results